πŸ‡ΊπŸ‡Έ FDA
Patent

US 8449909

Abuse-deterrent drug formulations

granted A61KA61K31/13A61K31/135

Quick answer

US patent 8449909 (Abuse-deterrent drug formulations) held by Collegium Pharmaceutical, Inc. expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Collegium Pharmaceutical, Inc.
Grant date
Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/13, A61K31/135, A61K31/20, A61K31/4458